Last Update Time:
05-Feb-2025 09:38:45
ISIN:
INE059A01026
Sector:
Healthcare
Symbol:
CIPLA
Cipla Limited
₹1,454.60
₹5.55
(0.38%)
▲
Prev. Close
₹1,449.05
Open
₹1,457.85
Close
₹0.00
Range
₹1,381.87 - ₹1,527.33
High
₹1,458.00
Low
₹1,440.05
Ind. Close
₹0.00
VWAP
₹1,449.12
The current stock price of Cipla Limited is ₹1,454.60, with a target price range between ₹1,381.87 and ₹1,527.33. The stock has experienced a price change of ₹5.55 (0.38%), reflecting recent market volatility.
Today's opening price was ₹1,457.85, while the previous close stood at ₹1,449.05. The intraday high reached ₹1,458.00, and the low touched ₹1,440.05. The volume-weighted average price (VWAP) is currently ₹1,449.12, indicating the stock's average traded price.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Cipla Limited Price Chart
Cipla Limited Pre Open Market Overview: 05-Feb-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 1457.85
- Previous Close Price: 1449.05
- Change: 8.80%
- Total Traded Volume: 2,247
- Total Buy Quantity: 6,034
- Total Sell Quantity: 20,159
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 1,449.05 | 488.00 | 0.00 |
| 1,449.10 | 10.00 | 0.00 |
| 1,449.80 | 6.00 | 0.00 |
| 1,450.00 | 24.00 | 0.00 |
| 1,455.00 | 1.00 | 0.00 |
| 1,457.85 | 0.00 | 46.00 |
| 1,458.00 | 0.00 | 88.00 |
| 1,458.05 | 0.00 | 6.00 |
| 1,459.00 | 0.00 | 423.00 |
| 1,459.05 | 0.00 | 1.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 1,454.60 | 75 | 1,454.85 | 4 |
| 1,454.45 | 3 | 1,454.90 | 967 |
| 1,454.40 | 1 | 1,454.95 | 34 |
| 1,454.35 | 13 | 1,455.00 | 140 |
| 1,454.30 | 33 | 1,455.10 | 4 |
Total Buy Quantity: 119,792
Total Sell Quantity: 108,768
Shareholding Patterns (in %) of Cipla Limited
| Category | 31-Dec-2023 | 31-Mar-2024 | 30-Jun-2024 | 30-Sep-2024 | 31-Dec-2024 |
|---|---|---|---|---|---|
| Promoter & Promoter Group | 33.47 | 33.47 | 30.91 | 30.92 | 29.19 |
| Public | 66.53 | 66.53 | 69.09 | 69.08 | 70.81 |
| Shares held by Employee Trusts | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Key Trade Statistics of Cipla Limited
The trade information for Cipla Limited includes a total traded volume of 0.95 lakh shares, and a traded value of ₹13.72 crore.
The market cap is ₹117,475.54 crore, with a free float market cap of ₹79,760.55 crore. The deliverable quantity is 1,045,302.00 shares, reflecting 59.71% of total trades.
Key risk indicators include security VaR at 9.64% and an applicable margin rate of 13.14%.
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 0.95 |
| Traded Value (₹ Cr.) | 13.72 |
| Total Market Cap (₹ Cr.) | 117,475.54 |
| Free Float Market Cap (₹ Cr.) | 79,760.55 |
| Impact cost | 0.02 |
| Quantity Traded | 1,750,660.00 |
| Deliverable Quantity | 1,045,302.00 |
| % of Quantity to Traded | 59.71 |
| Security VaR | 9.64 |
| Index VaR | N/A |
| VaR Margin | 9.64 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 13.14 |
| Face Value | 2 |
Key Price Statistics of Cipla Limited
The 52-week high for Cipla Limited was ₹1,702.05, recorded on 09-Oct-2024. On the other hand, the 52-week low stands at ₹1,317.25, with the lowest value recorded on 10-May-2024.
The upper band for trading is ₹N/A, and the lower band is ₹N/A. The price band is No Band%.
The stock's daily volatility stands at 1.53, while the annualized volatility is 29.23. The tick size for trading is ₹N/A.
| Price Information | Details |
|---|---|
| 52 Week High (09-Oct-2024) | 1,702.05 |
| 52 Week Low (10-May-2024) | 1,317.25 |
| Upper Band | 1,593.95 |
| Lower Band | 1,304.15 |
| Price Band (%) | No Band |
| Daily Volatility | 1.53 |
| Annualised Volatility | 29.23 |
| Tick Size | 0.05 |
Key Securities Statistics of Cipla Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 08-Feb-1995 |
| Adjusted P/E | 23.4 |
| Symbol P/E | 23.4 |
| Index | NIFTY 50 |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of Cipla Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Cipla Limited
| Subject | Date |
|---|---|
| Acquisition-XBRL | 04-Feb-2025 |
| General Updates | 03-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 31-Jan-2025 |
| Copy of Newspaper Publication | 29-Jan-2025 |
| Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent | 29-Jan-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 28-Jan-2025 |
| Integrated Filing- Financial | 28-Jan-2025 |
| Change in Management | 28-Jan-2025 |
Corporate Actions of Cipla Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 2 | Dividend - Rs 13 Per Share | 02-Aug-2024 |
| 2 | Dividend - Rs 8.50 Per Share | 21-Jul-2023 |
| 2 | Dividend - Rs 5 Per Share | 08-Aug-2022 |
| 2 | Annual General Meeting/Dividend - Rs 5 Per Share | 09-Aug-2021 |
| 2 | Annual General Meeting | 11-Aug-2020 |
| 2 | Interim Dividend - Rs 3 Per Share Special Dividend - Re 1 Per Share | 19-Mar-2020 |
| 2 | Annual General Meeting/Dividend - Rs 3 Per Share | 31-Jul-2019 |
| 2 | Annual General Meeting/Dividend- Rs 3 Per Share | 13-Aug-2018 |
| 2 | Annual General Meeting/Dividend - Rs 2/- Per Share | 26-Jul-2017 |
| 2 | Annual General Meeting/Dividend Rs 2/- Per Share | 12-Sep-2016 |
| 2 | Annual General Meeting/Dividend - Rs 2/- Per Share | 11-Aug-2015 |
| 2 | Annual General Meeting/Dividend Rs 2/- Per Equity Share | 06-Aug-2014 |
| 2 | Annual General Meeting/Dividend Rs 2/- Per Equity Share | 06-Aug-2013 |
| 2 | Annual General Meeting And Dividend - Rs.2/- Per Share | 01-Aug-2012 |
| 2 | Annual General Meeting And Dividend Rs.2/- Per Share | 09-Aug-2011 |
| 2 | Special Interim Dividend Re.0.80 Per Share | 03-Sep-2010 |
| 2 | Annual General Meeting And Dividend Rs.2/- Per Share | 23-Jul-2010 |
| 2 | Agm/Div-Rs.2/- Per Share | 10-Aug-2009 |
| 2 | Dividend - Rs.2 Per Share | 12-Aug-2008 |
| 2 | Agm/Div-Rs.2/- Per Sh | 08-Aug-2007 |
Board Meetings of Cipla Limited
Financial Results of Cipla Limited
| Qtr Ended | Tot. Income | Net P/L | EPS | Notes |
|---|---|---|---|---|
| 31 Dec 2024 | 515,957 | 143,815 | 17.81 | |
| 30 Sep 2024 | 506,417 | 117,816 | 14.59 | |
| 30 Jun 2024 | 471,457 | 105,594 | 13.08 | |
| 31 Mar 2024 | 457,527 | 103,840 | 12.16 | |
| 31 Dec 2023 | 455,031 | 111,414 | 12.61 |
Company Directory of Cipla Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.cipla.com | Registered Office | Cipla House Peninsula Business Park Ganpatrao Kadam Marg Lower Parel | MUMBAI |
| www.cipla.com | Transfer Agent | KFin Technologies Private Limited Selenium Tower B, Plot no. 31 & 32, Financial district, Nanakramguda, Serilingampally Hyderabad, Telangana, 500032 | HYDERABAD |
Insider Trading of Cipla Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Anusha Jain | 3181663 | Sell |
| 7(2) | Anusha Jain | 4763850 | Sell |
| 7(2) | Jaideep Mallick | 190470 | Buy |
| 7(2) | Priyanka Mallick | 237335 | Buy |
| 7(2) | Priyanka Mallick | 636640 | Buy |
| 7(2) | Vidya Prabhakar Rote jointly with Kiran Rote | 1110380 | Buy |
| 7(2) | Vidya Prabhakar Rote jointly with Kiran Rote | 1075900 | Pledge Revoke |
| 7(2) | Vidya Prabhakar Rote jointly with Kiran Rote | 1119150 | Pledge |
| 7(2) | Shachi Malpani | 9659500 | Pledge |
| 7(2) | Shachi Malpani | 10219500 | Buy |
| 7(2) | Anusha Dinesh Jain | 2084121 | Sell |
| 7(2) | Vikas Vij | 3666 | Buy |
| 7(2) | Ali akbar Rangwala | 3196 | Buy |
| 7(2) | Chandru Chawla | 47920 | Buy |
| 7(2) | Jinesh Chauhan | 2430 | Buy |
| 7(2) | Nihar Subhash Medh | 3666 | Buy |
| 7(2) | P L Srinivas | 3550 | Buy |
| 7(2) | Jortin George | 3778 | Buy |
| 7(2) | Kirit D Ladage | 5326 | Buy |
| 7(2) | Preeti Raut | 4664 | Buy |
Annual Reports of Cipla Limited
Investor Complaints of Cipla Limited
| Date | Pending | Received | Disposed | Unresolved |
|---|---|---|---|---|
| 31-Dec-2024 | 1 | 4 | 4 | 1 |
| 30-Sep-2024 | 4 | 5 | 8 | 1 |
| 30-Jun-2024 | 2 | 10 | 8 | 4 |
| 31-Mar-2024 | 0 | 5 | 3 | 2 |
| 31-Dec-2023 | 0 | 2 | 2 | 0 |
| 30-Sep-2023 | 0 | 4 | 4 | 0 |
| 30-Jun-2023 | 2 | 5 | 7 | 0 |
| 31-Mar-2023 | 2 | 14 | 14 | 2 |
| 31-Dec-2022 | 0 | 7 | 5 | 2 |
| 30-Sep-2022 | 2 | 6 | 8 | 0 |
| 30-Jun-2022 | 0 | 11 | 9 | 2 |
| 31-Mar-2022 | 5 | 4 | 9 | 0 |
| 31-Dec-2021 | 1 | 12 | 8 | 5 |
| 30-Sep-2021 | 0 | 1 | 0 | 1 |
| 30-Jun-2021 | 0 | 6 | 6 | 0 |
| 31-Mar-2021 | 0 | 3 | 3 | 0 |
| 31-Dec-2020 | 0 | 3 | 3 | 0 |
| 30-Sep-2020 | 0 | 4 | 4 | 0 |
| 30-Jun-2020 | 0 | 0 | 0 | 0 |
| 31-Mar-2020 | 1 | 5 | 6 | 0 |
| 31-Dec-2019 | 0 | 4 | 3 | 1 |
| 30-Sep-2019 | 0 | 4 | 4 | 0 |
| 30-Jun-2019 | 0 | 3 | 3 | 0 |
| 31-Mar-2019 | 1 | 5 | 6 | 0 |
| 31-Dec-2018 | 0 | 9 | 8 | 1 |
| 30-Sep-2018 | 0 | 6 | 6 | 0 |
| 30-Jun-2018 | 0 | 0 | 0 | 0 |
| 31-Mar-2018 | 2 | 1 | 3 | 0 |
| 31-Dec-2017 | 1 | 5 | 4 | 2 |
| 30-Sep-2017 | 2 | 3 | 4 | 1 |
| 30-Jun-2017 | 1 | 4 | 3 | 2 |
| 31-Mar-2017 | 0 | 1 | 0 | 1 |
| 31-Dec-2016 | 0 | 5 | 5 | 0 |
| 30-Sep-2016 | 0 | 3 | 3 | 0 |
| 30-Jun-2016 | 1 | 3 | 4 | 0 |
| 31-Mar-2016 | 0 | 7 | 6 | 1 |
| 31-Dec-2015 | 0 | 8 | 8 | 0 |
Event Calendar of Cipla Limited
| Purpose | Details |
|---|---|
| Results/Dividend | Inter-alia to consider the Annual Audited Accounts for the year ended March 31, 2010 and Recommendation of Dividend, if any. |
| Results/Dividend | Inter-alia to consider the Annual Audited Accounts for the year ended March 31, 2011 and Recommendation of Dividend, if any. |
| Results/Dividend | Inter-alia to consider the Annual Audited Accounts for the year ended March 31, 2012 and Recommendation of Dividend, if any. |
| Results | Inter alia to consider Unaudited Financial Results for third quarter ended December 31, 2012 . |
| Results/Dividend | Inter-alia to consider the Annual Audited Accounts for the year ended March 31, 2013 and Recommendation of Dividend, if any. |
| Results | inter alia, to consider Unaudited Financial Results for first quarter ended June 30, 2013. |
| Results | Inter-alia to consider Unaudited Financial Results for quarter and half year ended September 30, 2013. |
| Results/Others | Inter alia, to consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2013 (Q3). Pursuant to the above and in terms of Company s Code of Internal Procedures and Conduct for Prevention of Insider Trading, the trading window for dealing in the securities of the Company will remain closed from 6:00 p.m. on February 04, 2014 till completion of 24 hours after the unaudited financial results are made public. |
| Results/Others | Inter-alia to consider and approve the audited financial results of the Company for the year ended 31st March 2014 and recommendation of dividend, if any. Further, Pursuant to the above and in terms of Company s Code of Internal Procedures and Conduct for Prevention of Insider Trading, the trading window for dealing in the securities of the Company will remain closed from 6:00 p.m. on 21st May, 2014 till completion of 24 hours after the audited financial results are made public. |
| Results | Inter alia, to consider and approve unaudited financial results for the quarter ended June 30, 2014. Further that in terms of Company's Code of Internal Procedures and Conduct for Prevention of Insider Trading, the "trading window" for dealing in the securities of the company will remain closed from August 6, 2014 till completion of 24 hours after the unaudited financial results are made public. |
| Results | Inter alia to consider and approve unaudited financial results for the quarter and half year ended September 30, 2014. |
| Results | Inter alia, to consider and approve unaudited financial results for the quarter and nine months ended December 31, 2014. |
| Results/Dividend | Inter-alia to consider and approve audited financial results for the year ended March 31, 2015 and recommendation of dividend, if any. |
| Results | To consider and approve unaudited financial results for the quarter ended June 30, 2015. |
| Results | Inter-alia to consider and approve unaudited financial results for the quarter and half-year ended September 30, 2015. |
| Results | Inter-alia to consider and approve unaudited financial results for the quarter and nine months ended December 31, 2015. |
| Results/Dividend | Inter-alia to consider and approve audited financial results for the year ended March 31, 2016 and recommendation of dividend, if any. |
| Results | Inter-alia to consider and approve unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2016. |
| Results | inter-alia to consider and approve unaudited financial results(standalone and consolidated) for the quarter and half year ended September 30, 2016. |
| Raising of Funds | to inter-alia consider the proposal of raising funds through issue of equity shares or American depository receipts or global depository receipts or foreign currency convertible bonds or non-convertible debenture (in form of bonds or otherwise) or bonds or any other securities I financial instruments, whether denominated in Indian Rupee and/or foreign currency(ies), either by way of a public issue or by way of a private placement (including through a qualified institutions placement) in accordance with the provisions of the applicable law. The fund raising would be subject to necessary permissions, sanctions and approvals (including shareholders' approval and such other statutory approvals as may be required) and the provisions of the laws. |
| Results | inter alia to consider and approve unaudited financial results (standalone and consolidated) for the quarter and nine months ended December 31, 2016. |
| Results/Dividend | inter-alia to consider and approve audited financial results(standalone and consolidated) for the quarter and year ended March 31, 2017 and recommendation of dividend, if any. |
| Results | Inter alia to consider and approve unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2017. |
| Results | inter-alia to consider and approve unaudited Financial Results ( Standalone and Consolidated) for the quarter and half year ended September 30, 2017. |
| Results | inter alia to consider and approve unaudited financial results (standalone and consolidated) for the quarter and nine months ended December 31, 2017. |
| Fund Raising | This is to inform you that the meeting of the Board of Directors of the Company scheduled on Tuesday, 22nd May 2018 will inter-alia also consider obtaining an enabling approval from the shareholders at the forthcoming Annual General Meeting of the Company regarding the proposal of raising of funds through issue of securities whether denominated in Indian Rupee and/or foreign currency(ies) either by way of a public issue or by way of a private placement (including through a qualified institutions placement) in accordance with the provisions of the applicable law. Please treat this as the intimation required under Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2018 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
| Fund Raising | This is to inform you that the meeting of the Board of Directors of the Company scheduled on Wednesday, 22"d May 2019 will inter-alia also consider obtaining an enabling approval from the shareholders at the forthcoming Annual General Meeting of the Company regarding the proposal of raising of funds through issue of securities whether denominated in Indian Rupee and/or foreign currency(ies) either by way of a public issue or by way of a private placement (including through a qualified institutions placement) inaccordance with the provisions of the applicable law.The proposal is in line with the Company's previous years' practice of obtaining an enabling approval from the shareholders.Please treat this as the intimation required under Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2019 and dividend |
| Financial Results | To consider and approve the financial results for the period ended June 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
| Dividend | To consider and approve payment of Interim dividend for FY 2019-20 |
| Financial Results/Fund Raising | To consider and approve the financial results for the period ended March 31, 2020 and Fund Raising |
| Financial Results | This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 7th August, 2020 inter-alia to consider and approve unaudited standalone and consolidated financial results for the quarter ended 30th June, 2020.In terms of the Company s Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company has been closed from 1st July, 2020 till 9th August, 2020 (both days inclusive) |
| Financial Results | To consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2020 |
| Financial Results | To consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended 31st December, 2020. |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2021 and dividend |
| Financial Results | This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 5th August, 2021 inter-alia to consider and approve unaudited standalone and consolidated financial results for the quarter ended 30th June, 2021.ￂﾠIn terms of the Company s Code of Conduct for Prevention of Insider Trading, for the purposes of financial results, the Trading Window for dealing in the securities of the Company has been closed from 1st July, 2021 till 7th August, 2021. |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
| Financial results | Cipla Limited has informed the Exchange about Board Meeting to be held on 29-Jul-2022 to consider financial statements for the period ended June 2022 |
| Financial results | Cipla Limited has informed the Exchange about Board Meeting to be held on 04-Nov-2022 to consider financial statements for the period ended September 2022 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2022 |
| Financial Results/Dividend | Intimation of Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 ( Listing Regulations ). |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2023 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
| Financial Results | CIPLA : 22-Jan-2024 : The Company has informed the Exchange that a Board meeting to be held on January 25, 2024 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on January 22, 2024, To consider and approve the financial results for the period ended December 31, 2023 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2024 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Cipla Limited
Voting Results of Cipla Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 13-OCT-2024 | Postal Ballot | To appoint Ms Sharmila Paranjpe as an Independent Director of the Company |
| 13-OCT-2024 | Postal Ballot | To appoint Mr Kamil Hamied as a Non-Executive Director of the Company |
| 13-OCT-2024 | Postal Ballot | To appoint Mr Abhijit Joshi as a Non-Executive Director of the Company |
| 13-OCT-2024 | Postal Ballot | To appoint Mr Adil Zainulbhai as a Non-Executive Director of the Company |
| 13-OCT-2024 | Postal Ballot | To appoint Ms Maya Hari as an Independent Director of the Company |
| 20-AUG-2024 | AGM | To receive, consider and adopt the audited standalone financial statements of the Company for the financial year ended 31st March, 2024 and the reports of the Board of Directors and Auditor thereon |
| 20-AUG-2024 | AGM | To ratify remuneration of the cost auditor for the financial year ending 31st March, 2025 |
| 20-AUG-2024 | AGM | To approve the continuation of Dr Y K Hamied as Non-Executive Director |
| 20-AUG-2024 | AGM | To approve to not to fill the vacancy caused by retirement of Mr S Radhakrishnan |
| 20-AUG-2024 | AGM | To declare final dividend on equity shares |
| 20-AUG-2024 | AGM | To receive, consider and adopt the audited consolidated financial statements of the Company for the financial year ended 31st March, 2024 and the report of the Auditor thereon |
| 16-MAY-2024 | Postal Ballot | To appoint Dr Balram Bhargava as an Independent Director of the Company |
| 16-MAY-2024 | Postal Ballot | To approve the payment ofone-time long-term incentive to Mr. Umang Vohra, Managing Director and Global Chief Executive Officer |
| 10-AUG-2023 | AGM | To receive, consider and adopt the audited standalone financial statements of the Company for the financial year ended 31st March, 2023 and the reports of the Board of Directors and Auditor thereon |
| 10-AUG-2023 | AGM | To ratify remuneration of the cost auditor for the financial year ending 31st March, 2024 |
| 10-AUG-2023 | AGM | To re-appoint Mr Umang Vohra as director liable to retire by rotation |
| 10-AUG-2023 | AGM | To declare final dividend on equity shares |
| 10-AUG-2023 | AGM | To receive, consider and adopt the audited consolidated financial statements of the Company for the financial year ended 31st March, 2023 and the report of the Auditor thereon |
| 26-AUG-2022 | AGM | To receive, consider and adopt the audited standalone financial statements of the Company for the financial year ended 31st March, 2022 and the reports of the Board of Directors and Auditor thereon |
| 26-AUG-2022 | AGM | To receive, consider and adopt the audited consolidated financial statements of the Company for the financial year ended 31st March, 2022 and the report of the Auditor thereon |